| 靶点: |
IC50: ~1 µM (NGF), 2.7 μM (MSI RNA-binding) |
| 体内研究: |
Ro 08-2750(13.75 mg/kg;腹腔注射)可抑制体内髓系白血病模型中的白血病形成。 |
| 参考文献: |
1. Arkin MR, et al. Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov. 2004 Apr;3(4):301-17. 2. Niederhauser O, et al. NGF ligand alters NGF signaling via p75(NTR) and trkA. J Neurosci Res. 2000 Aug 1;61(3):263-72. 3. Minuesa G, et al. Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia. Nat Commun. 2019 Jun 19;10(1):2691. |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.7 ml |
18.502 ml |
37.003 ml |
| 5 mM |
0.74 ml |
3.7 ml |
7.401 ml |
| 10 mM |
0.37 ml |
1.85 ml |
3.7 ml |
| 50 mM |
0.074 ml |
0.37 ml |
0.74 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |